drugset / Trial / NCT04080531
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Phase 4
Completed
165 enrolled
Emory University
National Cancer Institute (NCI) · collabNational Institutes of Health (NIH) · collabSanofi · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This phase IV trial studies how well influenza vaccination works in preventing infections such as influenza in patients with plasma cell disorders. Influenza infections may theoretically support the growth of tumor cells and improving protection against influenza may improve the status of patients' plasma cell disorder. Giving influenza vaccination may reduce influenza-related complications including infections, hospitalizations, and deaths, and improve the status of plasma cell disorders.
Timeline
- Start
- 2019-10-18
- Primary completion
- 2021-05-11
- Completion
- 2022-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | — | Intramuscular |
| Background | Prevnar 13 | Vaccine | — | Intramuscular |